A Phase 2 Study of Luspatercept in Patients with Myelofibrosis-Associated Anemia

被引：57

作者：

Gerds, Aaron T. ^{[1
]}

Vannucchi, Alessandro M. ^{[2
]}

Passamonti, Francesco ^{[3
]}

Kremyanskaya, Marina ^{[4
]}

Gotlib, Jason R. ^{[5
]}

Palmer, Jeanne M. ^{[6
]}

McCaul, Kelly ^{[7
]}

Ribrag, Vincent ^{[8
]}

Mead, Adam J. ^{[9
]}

Harrison, Claire N. ^{[10
]}

Mesa, Ruben A. ^{[11
]}

Kiladjian, Jean-Jacques ^{[12
]}

Barosi, Giovanni ^{[13
]}

Gale, Robert Peter ^{[14
,15
]}

Laadem, Abderrahmane ^{[15
]}

Pariseau, Joseph ^{[15
]}

Gerike, Torsten ^{[15
]}

Zhang, Jennie ^{[15
]}

Linde, Peter G. ^{[16
]}

Reynolds, Joseph G. ^{[16
]}

Verstovsek, Srdan ^{[17
]}

机构：

[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[2] Univ Florence, Ctr Res & Innovat Myeloproliferat Neoplasms, AOU Careggi, Florence, Italy

[3] Univ Insubria, Dept Med & Surg, Varese, Italy

[4] Mt Sinai Hosp, Icahn Sch Med, Tisch Canc Inst, Div Hematol & Med Oncol, New York, NY USA

[5] Stanford Canc Inst, Stanford, CA USA

[6] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA

[7] Avera Canc Inst, Sioux Falls, SD USA

[8] Inst Gustave Roussy, Villejuif, France

[9] Oxford Univ Hosp NHS Fdn Trust, Oxford, England

[10] Guys & St Thomas NHS Fdn Trust, London, England

[11] UT Hlth San Antonio Canc Ctr, San Antonio, TX USA

[12] Hop St Louis, Paris, France

[13] IRCCS Policlin San Matteo Fdn, Pavia, Italy

[14] Imperial Coll London, Div Expt Med, Dept Med, Hematol Res Ctr, London, England

[15] Celgene Corp, Summit, NJ USA

[16] Acceleron Pharma, Cambridge, MA USA

[17] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-122546

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

557

引用

页数：6